408 related articles for article (PubMed ID: 37492224)
21. Cancer stem cells and tumorigenesis.
Zhu P; Fan Z
Biophys Rep; 2018; 4(4):178-188. PubMed ID: 30310855
[TBL] [Abstract][Full Text] [Related]
22. Deciphering Potential Role of Hippo Signaling Pathway in Breast Cancer: A Comprehensive Review.
Bhavnagari H; Raval A; Shah F
Curr Pharm Des; 2023; 29(44):3505-3518. PubMed ID: 38141194
[TBL] [Abstract][Full Text] [Related]
23. Profiling and targeting cancer stem cell signaling pathways for cancer therapeutics.
Borlongan MC; Wang H
Front Cell Dev Biol; 2023; 11():1125174. PubMed ID: 37305676
[TBL] [Abstract][Full Text] [Related]
24. Cancer stem cell in breast cancer therapeutic resistance.
Bai X; Ni J; Beretov J; Graham P; Li Y
Cancer Treat Rev; 2018 Sep; 69():152-163. PubMed ID: 30029203
[TBL] [Abstract][Full Text] [Related]
25. Esophageal cancer stem cells and implications for future therapeutics.
Qian X; Tan C; Wang F; Yang B; Ge Y; Guan Z; Cai J
Onco Targets Ther; 2016; 9():2247-54. PubMed ID: 27143920
[TBL] [Abstract][Full Text] [Related]
26. CONSORT: Sam68 Is Directly Regulated by MiR-204 and Promotes the Self-Renewal Potential of Breast Cancer Cells by Activating the Wnt/Beta-Catenin Signaling Pathway.
Wang L; Tian H; Yuan J; Wu H; Wu J; Zhu X
Medicine (Baltimore); 2015 Dec; 94(49):e2228. PubMed ID: 26656364
[TBL] [Abstract][Full Text] [Related]
27. Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence.
Aramini B; Masciale V; Grisendi G; Bertolini F; Maur M; Guaitoli G; Chrystel I; Morandi U; Stella F; Dominici M; Haider KH
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205721
[TBL] [Abstract][Full Text] [Related]
28. A novel lncRNA ROPM-mediated lipid metabolism governs breast cancer stem cell properties.
Liu S; Sun Y; Hou Y; Yang L; Wan X; Qin Y; Liu Y; Wang R; Zhu P; Teng Y; Liu M
J Hematol Oncol; 2021 Oct; 14(1):178. PubMed ID: 34715882
[TBL] [Abstract][Full Text] [Related]
29. Self-Renewal Signalling Pathway Inhibitors: Perspectives on Therapeutic Approaches for Cancer Stem Cells.
Zhu Q; Shen Y; Chen X; He J; Liu J; Zu X
Onco Targets Ther; 2020; 13():525-540. PubMed ID: 32021295
[TBL] [Abstract][Full Text] [Related]
30. MicroRNAs, a subpopulation of regulators, are involved in breast cancer progression through regulating breast cancer stem cells.
Fan X; Chen W; Fu Z; Zeng L; Yin Y; Yuan H
Oncol Lett; 2017 Nov; 14(5):5069-5076. PubMed ID: 29142594
[TBL] [Abstract][Full Text] [Related]
31. Role, molecular mechanism and the potential target of breast cancer stem cells in breast cancer development.
Zhang T; Zhou H; Wang K; Wang X; Wang M; Zhao W; Xi X; Li Y; Cai M; Zhao W; Xu Y; Shao R
Biomed Pharmacother; 2022 Mar; 147():112616. PubMed ID: 35008001
[TBL] [Abstract][Full Text] [Related]
32. Cancer stem cells in colorectal cancer: Signaling pathways involved in stemness and therapy resistance.
Ebrahimi N; Afshinpour M; Fakhr SS; Kalkhoran PG; Shadman-Manesh V; Adelian S; Beiranvand S; Rezaei-Tazangi F; Khorram R; Hamblin MR; Aref AR
Crit Rev Oncol Hematol; 2023 Feb; 182():103920. PubMed ID: 36702423
[TBL] [Abstract][Full Text] [Related]
33. Regulation of Metabolic Plasticity in Cancer Stem Cells and Implications in Cancer Therapy.
Papadaki S; Magklara A
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497394
[TBL] [Abstract][Full Text] [Related]
34. DNMT1-mediated methylation of BEX1 regulates stemness and tumorigenicity in liver cancer.
Wang Q; Liang N; Yang T; Li Y; Li J; Huang Q; Wu C; Sun L; Zhou X; Cheng X; Zhao L; Wang G; Chen Z; He X; Liu C
J Hepatol; 2021 Nov; 75(5):1142-1153. PubMed ID: 34217777
[TBL] [Abstract][Full Text] [Related]
35. Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype.
Jang GB; Kim JY; Cho SD; Park KS; Jung JY; Lee HY; Hong IS; Nam JS
Sci Rep; 2015 Jul; 5():12465. PubMed ID: 26202299
[TBL] [Abstract][Full Text] [Related]
36. Key Roles of Hyaluronan and Its CD44 Receptor in the Stemness and Survival of Cancer Stem Cells.
Chanmee T; Ontong P; Kimata K; Itano N
Front Oncol; 2015; 5():180. PubMed ID: 26322272
[TBL] [Abstract][Full Text] [Related]
37. The Role of Breast Cancer Stem Cells as a Prognostic Marker and a Target to Improve the Efficacy of Breast Cancer Therapy.
Scioli MG; Storti G; D'Amico F; Gentile P; Fabbri G; Cervelli V; Orlandi A
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31330794
[TBL] [Abstract][Full Text] [Related]
38. BCL11A enhances stemness and promotes progression by activating Wnt/β-catenin signaling in breast cancer.
Zhu L; Pan R; Zhou D; Ye G; Tan W
Cancer Manag Res; 2019; 11():2997-3007. PubMed ID: 31114347
[No Abstract] [Full Text] [Related]
39. Novel Therapeutics Against Breast Cancer Stem Cells by Targeting Surface Markers and Signaling Pathways.
Das PK; Rakib MA; Khanam JA; Pillai S; Islam F
Curr Stem Cell Res Ther; 2019; 14(8):669-682. PubMed ID: 31808385
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of NF-κB Signaling Reduces the Stemness Characteristics of Lung Cancer Stem Cells.
Zakaria N; Mohd Yusoff N; Zakaria Z; Widera D; Yahaya BH
Front Oncol; 2018; 8():166. PubMed ID: 29868483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
